Rick E. Winningham is CEO at Theravance Biopharma, Inc. (TBPH). They have made 19 open-market trades across 3 companies since 2008, most recently 2026-08-20.
CIK 0001302443
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
3 open-market purchases totalling $1.4M since 2008, against 16 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| TBPH | 1,611,022 | $27.5M |
| THRX | 825,391 | $3.4M |
| JAZZ | 11,172 | $2.3M |
| Total | $33.2M |
Shares reported on the most recent Form 4, priced at the 2026-08-24 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| JAZZ | SELL | 2026-05-22 | 2026-05-27 | $241.57 | $662K | -2.0% | -2.7% | +10.0% |
| JAZZ | SELL | 2025-11-18 | 2025-11-20 | $180.86 | $2.0M | -4.8% | -3.4% | -3.9% |
| JAZZ | SELL | 2023-08-14 | 2023-08-15 | $138.16 | $343K | +1.5% | -3.8% | -12.3% |
| TBPH | SELL | 2022-12-14 | 2022-12-16 | $11.19 | $560K | +3.7% | +5.5% | -1.2% |
| JAZZ | SELL | 2022-08-08 | 2022-08-09 | $152.32 | $332K | -0.7% | -3.9% | -7.8% |
| JAZZ | SELL | 2021-08-06 | 2021-08-10 | $147.96 | $386K | -7.6% | -7.0% | -7.7% |
| JAZZ | SELL | 2020-08-07 | 2020-08-10 | $125.87 | $234K | -2.0% | +10.9% | +15.0% |
| JAZZ | SELL | 2019-08-09 | 2019-08-12 | $135.65 | $197K | -3.2% | -1.3% | -3.1% |
| JAZZ | SELL | 2018-08-09 | 2018-08-13 | $176.19 | $4.3M | -3.5% | -5.6% | -15.5% |
| JAZZ | SELL | 2017-08-11 | 2017-08-14 | $142.36 | $188K | +2.7% | +5.7% | -5.5% |
| TBPH | BUY | 2017-08-11 | 2017-08-11 | $24.50 | $245K | +10.2% | +28.0% | +10.4% |
| JAZZ | SELL | 2017-06-01 | 2017-06-02 | $150.00 | $750K | +2.3% | +6.1% | +1.0% |
| JAZZ | SELL | 2016-08-15 | 2016-08-17 | $136.45 | $86K | -7.5% | -8.0% | -18.0% |
| JAZZ | SELL | 2016-08-15 | 2016-08-17 | $136.45 | $86K | -7.5% | -8.0% | -18.0% |
| TBPH | BUY | 2015-08-14 | 2015-08-17 | $11.86 | $949K | -16.4% | +1.4% | +1.4% |
| JAZZ | SELL | 2015-08-10 | 2015-08-11 | $180.00 | $144K | -10.8% | -0.4% | -0.4% |
| JAZZ | SELL | 2014-08-12 | 2014-08-14 | $133.15 | $145K | -10.8% | -0.4% | -0.4% |
| JAZZ | SELL · 10b5-1 | 2014-04-17 | 2014-04-21 | $140.00 | $3.9M | -10.8% | -0.4% | -0.4% |
| THRX | SELL · 10b5-1 | 2013-09-12 | 2013-09-13 | $40.03 | $895K | -6.0% | -1.1% | -1.1% |
| JAZZ | SELL | 2013-08-13 | 2013-08-14 | $81.86 | $88K | -10.8% | -0.4% | -0.4% |
| THRX | SELL · 10b5-1 | 2013-04-30 | 2013-05-02 | $33.64 | $8.6M | -6.0% | -1.1% | -1.1% |
| THRX | SELL · 10b5-1 | 2012-08-03 | 2012-08-07 | $27.95 | $2.1M | -6.0% | -1.1% | -1.1% |
| THRX | SELL · 10b5-1 | 2011-05-10 | 2011-05-12 | $26.34 | $3.4M | -6.0% | -1.1% | -1.1% |
| THRX | SELL · 10b5-1 | 2011-03-01 | 2011-03-03 | $22.53 | $1.4M | -6.0% | -1.1% | -1.1% |
| THRX | SELL · 10b5-1 | 2011-02-24 | 2011-02-28 | $22.24 | $5.6M | -6.0% | -1.1% | -1.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.